2016

1. Sasaki E, Iida A, Oda S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Pathogenic analysis of carbamazepine-induced liver injury in F344 rats focused on immune-and inflammation-related facters. Exp Toxicol Pathol. 2016 Jan;68(1):27-38.

2. Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. A role of regulatory T cell in the pathogenesis of IBD. World J Gastroenterol. 2016 Feb21;22(7):2195-2205.

3. Kondo T, Tsunematsu T, Yamada A, Arakaki R, Saito M, Otsuka K, Kujiraoka S, Ushio A, Kurosawa M, Kudo Y, Ishimaru N. Acceleration of Tumor Growth due to Dysfunction in M1 Macrophages and Enhanced Angiogenesis in an Animal Model of Autoimmune Disease. Lab Invest. 2016 Jan 25.

4. Obayashi M, Yoshida M, Tsunematsu T, Ogawa I, Sasahira T, Kuniyasu H, Imoto I, Abiko Y, Xu D, Fukunaga S, Tahara H, Kudo Y, Nagao T, Takata T. MicroRNA-203 Suppresses Invasion and Epithelial-mesenchymal Transition Induction via Targeting NUAK1 and SNAI2 in Head and Neck Cancer. Oncotarget. 2016 Jan 22.

5. Saito M, Arakaki R, Yamada A, Tsunematsu T, Kudo Y, Ishimaru N. Molecular Mechanisms of Nickel Allergy. Int J Mol Sci. 2016 Feb 2;17(2).

6. Qi G, Kudo Y, Tang B, Liu T, Jin S, Liu J, Zuo X, Mi S, Shao W, Ma X, Tsunematsu T, Ishimaru N, Zeng S, Tstsuka M, Shimamoto F. PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer. Oncotarget. 2016 Feb 25.

7. Kudo Y, Tada H, Fujiwara N, Tada Y, Tsunematsu T, Miyake Y, Ishimaru N. Oral environment and cancer. Gene Environ 2016 Aug 1;38:13.

8. Tsunematsu T, Fujiwara N, Yoshida M, Takayama Y, Kujiraoka S, Qi G, Kitagawa M, Kondo T, Yamada A, Arakaki R, Miyauchi M, Ogawa I, Abiko Y, Nikawa H, Murakami S, Takata T, Ishimaru N, Kudo Y. Human odontogenic epithelial cells derived from epithelial rests of Malasses stem cell properities. Lab Invest 2016 Oct;96(10):1063-75.

9. Izawa T, Arakaki R, Mori H, Tsunematsu T, Kudo Y, Tanaka E, Ishimaru N. The nuclear receptor AhR controls bone homeostasis by regulating osteoclast differentiation via the RANK/c-FOS signaling axis. J Immunol 2016 Dec 15;197(12):4639-4650.

10. Ando T, Kudo Y, Iizuka S, Tsunematsu T, Umehara H, Shrestha M, Matsuo T, Kubo T, Shimose S, Arihiro K, Ogawa I, Ochi M, Takata T. Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma. Sci. Rep 2017 Jan 5;7:40187.

11. Qi G, Liu J, Mi S, Tsunematsu T, Jin S, Shao W, Liu T, Ishimaru N, Tang T, Kudo Y. Aurora kinase inhibitors in head and neck cancer. Curr. Top Med.Chem 2018 Jan 12.

12. Yang GX, Sun Y, Tsuneyama K, Zhang W, Leung PS, He XS, et al. Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice. Clin Exp Immunol. 2016;185(2):154-64.

13. Wakae H, Higashide T, Tsuneyama K, Nakamura T, Takahashi K, Sugiyama K. Immunohistochemical Characterization of the Ectopic Epithelium Devoid of Goblet Cells From a Posttraumatic Iris Cyst Causing Mucogenic Glaucoma. J Glaucoma. 2016;25(3):e291-4.

14. Takikawa A, Usui I, Fujisaka S, Ikutani M, Senda S, Hattori S, et al. Deletion of SIRT1 in myeloid cells impairs glucose metabolism with enhancing inflammatory response to adipose tissue hypoxia. Diabetology International. 2016;7(1):59-68.

15. Takahashi T, Nishida T, Baba H, Hatta H, Imura J, Sutoh M, et al. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse). Mol Clin Oncol. 2016;5(2):267-70.

16. Takikawa A, Mahmood A, Nawaz A, Kado T, Okabe K, Yamamoto S, et al. HIF-1alpha in Myeloid Cells Promotes Adipose Tissue Remodeling Toward Insulin Resistance. Diabetes. 2016;65(12):3649-59.

17. Taira S, Yamaguchi N, Tatsuta Y, Katano H, Tsuneyama K, Kikuchi K. Liver disease risk of xenobiotics due to percutaneous absorption revealed by nano-PALDI imaging mass spectrometry. Int J Recent Sci Res 2016;7(7):12589-92.

18. Oda S, Shirai Y, Akai S, Nakajima A, Tsuneyama K, Yokoi T. Toxicological role of an acyl glucuronide metabolite in diclofenac-induced acute liver injury in mice. J Appl Toxicol. 2016.

19. Nishida T, Tsuneyama K, Fujimoto M, Nomoto K, Hayashi S, Miwa S, et al. Aberrant iron metabolism might have an impact on progression of diseases in Tsumura Suzuki obese diabetes mice, a model of spontaneous metabolic syndrome. Pathol Int. 2016;66(11):622-8.

20. Morimoto S, Ishikawa T, Hyodo K, Yamazaki T, Taira S, Tsuneyama K, et al. Preparation and characterization of newly developed matrix using functional γ‐Fe2O3 nanoparticles for mass spectrometry in small molecules. Surf Interface Anal 2016;48:1127-31.

21. Kawaguchi M, Hara N, Bilim V, Koike H, Suzuki M, Kim TS, et al. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression. BMC Cancer. 2016;16(1):805.

22. Iwamura A, Watanabe K, Akai S, Nishinosono T, Tsuneyama K, Oda S, et al. Zomepirac Acyl Glucuronide Is Responsible for Zomepirac-Induced Acute Kidney Injury in Mice. Drug Metab Dispos. 2016;44(7):888-96.

23. Bae HR, Leung PS, Tsuneyama K, Valencia JC, Hodge DL, Kim S, et al. Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology. 2016;64(4):1189-201.

24. Akai S, Uematsu Y, Tsuneyama K, Oda S, Yokoi T. Kupffer cell-mediated exacerbation of methimazole-induced acute liver injury in rats. J Appl Toxicol. 2016;36(5):702-15.